Erratum: Antidiabetic and adipogenic properties in a newly synthesized thiazolidine derivative, FPFS-410Q (Metabolism: Clinical and Experimental (December 2004) 53 (1532-1537) DOI: 10.1016/j.metabol.2004.06.020);Antidiabetic and adipogenic properties in a newly synthesized thiazolidine derivative, FPFS-410

Metabolism: Clinical and Experimental

Volumn 53, Issue 12, 2004, Pages 1532-1537

  Norisada, Nobuyoshi ^a,b   Masuzaki, Hiroaki ^a   Fujimoto, Muneya ^a   Inoue, Gen ^a   Hosoda, Kiminori ^a   Hayashi, Tatsuya ^a   Watanabe, Mayumi ^b   Muraoka, Shizuko ^b   Yoneda, Fumio ^b   Nakao, Kazuwa ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Fujimoto Pharmaceutical Corporation   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; FPFS 410; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DIABETIC OBESITY; DISEASE SEVERITY; DRUG DETERMINATION; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; DYSLIPIDEMIA; GENETICS; GLUCOSE TRANSPORT; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; LIPID STORAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; REPORTER GENE;

EID: 9344227320     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.09.001     Document Type: Erratum

References (26)

1. Zhang Y., Proenca R., Maffei M., et al. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432
2. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha Direct role in obesity-linked insulin resistance. Science. 259:1993;87-91
3. Scherer P.E., Williams S., Fogliano M., et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 270:1995;26746-26749
4. Tontonoz P., Hu E., Graves R.A., et al. mPPAR gamma 2 Tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8:1994;1224-1234
5. Saltiel A.R., Olefsky J.M. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes. 45:1996;1661-1669
6. Lehmann J.M., Moore L.B., Smith-Oliver T.A. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator- activated receptor gamma (PPAR gamma). J Biol Chem. 270:1995;12953-12956
7. Wang C.H., Weisel R.D., Liu P.P., et al. Glitazones and heart failure Critical appraisal for the clinician. Circulation. 107:2003;1350-1354
8. Scheen A.J. Thiazolidinediones and liver toxicity. Diabetes Metab. 27:2001;305-313
9. Dey D., Medicherla S., Neogi P., et al. A novel peroxisome proliferator-activated gamma (PPAR gamma) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential. Metabolism. 52:2003;1012-1018
10. Rocchi S., Picard F., Vamecq J., et al. A unique PPAR gamma ligand with potent insulin-sensitizing yet weak adipogenic activity. Mol Cell. 8:2001;737-747
11. Henke B.R., Blanchard S.G., Brackeen M.F., et al. N-(2-Benzoylphenyl)-L- tyrosine PPAR gamma agonists 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. J Med Chem. 41:1998;5020-5036
12. Yoneda F., Ohde H., Watanabe M., et al. WO 01/36402 PCT Int Appl. 2001
13. Yoneda F., Muraoka S., Ohde H., et al. WO 01/52849 PCT Int Appl. 2001
14. Kliewer S.A., Forman B.M., Blumberg B., et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA. 91:1994;7355-7359
15. Student A.K., Hsu R.Y., Lane M.D. Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. J Biol Chem. 255:1980;4745-4750
16. Ramirez-Zacarias J.L., Castro-Munozledo F., Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry. 97:1992;493-497
17. Inoue G., Kuzuya H., Hayashi T., et al. Effects of ML-9 on insulin stimulation of glucose transport in 3T3-L1 adipocytes. J Biol Chem. 268:1993;5272-5278
18. Lebovitz H.E. Differentiating members of the thiazolidinedione class A focus on safety. Diabetes Metab Res Rev. 18:2002;S23-S29
19. Willson T.M., Cobb J.E., Cowan D.J., et al. The structure-activity relationship between peroxisome proliferator-activated receptor gamma agonism and the antihyperglycemic activity of thiazolidinediones. J Med Chem. 39:1996;665-668
20. Darlington G.J., Ross S.E., MacDougald O.A. The role of C/EBP genes in adipocyte differentiation. J Biol Chem. 273:1998;30057-30060
21. Tanaka T., Yoshida N., Kishimoto T., et al. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 16:1997;7432-7443
22. Yamamoto H., Kurebayashi S., Hirose T., et al. Reduced IRS-2 and GLUT4 expression in PPAR gamma2-induced adipocytes derived from C/EBPbeta and C/EBPdelta-deficient mouse embryonic fibroblasts. J Cell Sci. 115:2002;3601-3607
23. Elisaf M. Effects of fibrates on serum metabolic parameters. Curr Med Res Opin. 18:2002;269-276
24. Guerre-Millo M., Gervois P., Raspe E., et al. Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem. 275:2000;16638-16642
25. Ye J.M., Doyle P.J., Iglesias M.A., et al. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats Comparison with PPAR-gamma activation. Diabetes. 50:2001;411-417
26. Tanaka T., Yamamoto J., Iwasaki S., et al. Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci USA. 100:2003;15924-15929